- 1 What is the potential benefit?
- 2 Who is a suitable candidate?
- 3 Who is NOT a suitable candidate for an autologous bio-cellular treatment?
- 4 What skin, soft tissue, and musculoskeletal tissues can be treated?
- 5 What are the risks?
- 6 How do I obtain a price quote for an autologous bio-cellular treatment at MRM?
- 7 At which locations is the treatment performed?
- 8 What if I am a suitable candidate for treatment?
- 9 Where do the regenerative cell populations come from?
- 10 What is the success rate?
- 11 Does treatment consist of one or multiple injections?
- 12 Free Consultation
What is the potential benefit?
Autologous bio-celluar treatments provide a non-surgical treatment option to reduce pain and promote natural healing and tissue regeneration, while still providing long-lasting relief, or potentially a cure, from a degenerative skin or soft tissue or musculoskeletal condition.
Who is a suitable candidate?
In general, autologous bio-cellular treatments can be appropriate for patients suffering from degenerative skin, soft tissue, or musculoskeletal conditions. This includes mild to moderate osteoarthritis affecting body areas such as the knee, shoulder, ankle, foot, hand, or digits. Bio-cellular treatments can also be appropriate for patients with skin and soft tissue conditions such as aging skin, wounds, scars, scalp hair loss, men’s sexual health issues, chronic tendinitis, partially torn tendons, damaged musculoskeletal tissues, including degeneration of the rotator cuff, labrum, meniscus, or avascular necrosis of bone.
Who is NOT a suitable candidate for an autologous bio-cellular treatment?
Conditions excluding a patient from being a suitable candidate for an autologous bio-cellular treatment at MRM include:
- a patient with active cancer not in remission for at least 5 years; or prior lymphoma or leukemia
- a patient with a current or active infection
- a patient needing to take blood thinners (Warfarin or Coumadin)
- a patient needing to take anti-platelet medications (such as to prevent stroke or stenosis of coronary stent)
- a patient with complex or severe medical issues
What skin, soft tissue, and musculoskeletal tissues can be treated?
The most common degenerative conditions treated with autologous bio-cellular agents include the face and body areas for skin and soft tissue regeneration and fat volume replacement, scars and wounds for skin and soft tissue regeneration, the penis for skin and soft tissue regeneration and girth enhancement, and the knee, shoulder, ankle, hand, digits, and tendons for musculoskeletal tissue regeneration.
What are the risks?
An autologous bio-cellular treatment is a safe surgical treatment with minimal risks. Since the population of regenerative cells comes from your own body, there is no chance of rejection or allergic reaction to these bio-cellular agents. There is a small risk of infection, just like with any minimally invasive surgical procedure. However, aseptic skin preparations are used at MRM for all bio-cellular treatments. You can expect some soreness for a few days at the harvest site and recipient injection site following the procedure.
How do I obtain a price quote for an autologous bio-cellular treatment at MRM?
A price quote for a bio-cellular treatment at MRM is provided by Dr. Roger Hogue during your complimentary consultation. The price quote is determined by the autologous bio-cellular agents used and the area(s) treated.
At which locations is the treatment performed?
Our regenerative medicine specialist, Dr. Roger Hogue, at Minnesota Regenerative Medicine currently provides autologous bio-cellular treatments only at our Maple Grove facility. A simple bio-cellular treatment session can take less than an hour to perform, whereas a more complex bio-cellular treatment session can take several hours to perform.
What if I am a suitable candidate for treatment?
If you can make the trip, we recommend that you schedule an appointment for a regenerative medicine consultation to determine if you are a suitable candidate for an autologous bio-cellular treatment. To expedite this process, we ask that you bring with you a printed copy of typed results or reports of your MRI or Xray imaging studies for our specialists to review, as well as any other pertinent medical records.
Where do the regenerative cell populations come from?
The autologous bio-cellular agents used during a regenerative medicine treatment at MRM are harvested from the patient’s own body.
What is the success rate?
Since we began performing autologous bio-cellular treatments in 2011, our experience has been that most patients experience some degree of pain relief and functional improvement in the degenerative conditions that received treatment. It is unusual for a patient not to experience some degree of pain relief or functional improvement following an autologous bio-cellular treatment at MRM.
Sometimes, for large joints such as shoulders and knees, we recommend platelet-rich plasma (PRP) injections be performed monthly for 2 consecutive months after the initial regenerative medicine treatment to maximize treatment results and ongoing tissue regeneration. This recommendation is based on the understanding that since growth factors and bioactive agents in PRP stimulate neighboring regenerative cell populations to continue to divide and differentiate. Each PRP treatment beyond the initial regenerative medicine treatment session will incur an additional charge. Ongoing clinical improvement following the initial bio-cellular treatment can continue for a year or more.
Does treatment consist of one or multiple injections?
The number of injections per treatment session can vary. It depends on the number of areas treated, and the size, severity, and complexity of the degenerative condition being treated.